XML 79 R66.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based Payments (Summary of Share Unit Activity) (Details)
3 Months Ended
Mar. 31, 2025
$ / shares
shares
Performance Share Units (Performance Conditions) | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 450,175
Granted, Shares | shares 148,585
Vested and settled, Shares | shares (132,018)
Forfeited, Shares | shares (2,930)
Outstanding ending balance, Shares | shares 463,812
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 64.73
Granted, Weighted average grant date fair value (usd per share) | $ / shares 95.64
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 58.74
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 67.31
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 76.32
Performance Share Units (Market Conditions) | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 268,954
Granted, Shares | shares 148,355
Vested and settled, Shares | shares 0
Forfeited, Shares | shares (1,645)
Outstanding ending balance, Shares | shares 415,664
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 105.53
Granted, Weighted average grant date fair value (usd per share) | $ / shares 139.95
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 0
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 120.49
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 117.76
Restricted Share Units | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 607,805
Granted, Shares | shares 436,754
Vested and settled, Shares | shares (250,885)
Forfeited, Shares | shares (11,630)
Outstanding ending balance, Shares | shares 782,044
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 66.00
Granted, Weighted average grant date fair value (usd per share) | $ / shares 97.16
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 62.27
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 69.99
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 84.54
Deferred Share Units | Liability-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 73,490
Granted, Shares | shares 219
Vested and settled, Shares | shares 0
Forfeited, Shares | shares 0
Outstanding ending balance, Shares | shares 73,709
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 40.29
Granted, Weighted average grant date fair value (usd per share) | $ / shares 97.30
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 0
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 0
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 40.45